# Rolipram to Treat Multiple Sclerosis

> **NCT00011375** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 52 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Rolipram

## Key facts

- **NCT ID:** NCT00011375
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** 52 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00011375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00011375, "Rolipram to Treat Multiple Sclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00011375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*